TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.
Kortleve D, Hammerl D, van Brakel M, Wijers R, Roelofs D, Kroese K, Timmermans MM, Liao CY, Huang S, Trapman-Jansen A, Foekens R, Michaux J, de Beijer MTA, Buschow SI, Demmers JAA, Kok M, Danen EHJ, Bassani-Sternberg M, Martens JWM, Abbott RJM, Debets R.
Kortleve D, et al. Among authors: abbott rjm.
Cancer Discov. 2024 Dec 2;14(12):2450-2470. doi: 10.1158/2159-8290.CD-24-0168.
Cancer Discov. 2024.
PMID: 39172012
Free PMC article.